Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhenyuan Capsule for stable coronary heart disease with abnormal glucose and lipid metabolism
ChiCTR-TRC-14004639Phase 4Not yet recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Zhenyuan Capsule in coronary arteriosclerosis, dysglycemia and dyslipidemia (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoints: glycated hemoglobin, fasting blood glucose and 2 more. Planned start Apr 2014; status: not yet recruiting.
02
Drugs
Zhenyuan Capsule
03
Conditions
coronary arteriosclerosisdysglycemiadyslipidemia
Beyond the preview
Go deeper on ChiCTR-TRC-14004639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004639.